• Supporting Breastfeeding: Herb and Supplement use in Lactation.

    Original Date: June 7, 2014
    Presenter: Regina Flanagan, ND

    Dr. Flanagan will discuss the hormone pathways active during breastfeeding and how supplements, herbs and pharmaceuticals interact with those pathways. She will explain the mechanical and social barriers and supports to breastfeeding and how to help our patients be successful breast feeding their babies.

    1.5 CEUs (0.25 pharmacy and 1.5 obstetrics) for NDs approved by OBNM

  • Infertility Case Presentation and Naturopathic Medicine

    Original Date: June 7, 2014
    Presenter: Kimberly Windstar, MEd, ND

    This presentation will provide a brief overview of infertility, case presentation and evidence based practice implementation of fertility affected by thyroid, MTHFR mutations, luteal phase defect and aspects of PCOS. The cases will elucidate the importance of testing for, using thyroid medication and monitoring, testing MTHFR mutations and appropriate supplementation, testing for luteal phase defect and appropriately treating with progesterone as well as ovarian dysfunction associated with PCOS and appropriate supplementation to positively influence fertility outcomes. Participants will be able to apply work up and treatment protocols in practice after the presentation.

    1.5 CEUs (0.25 pharmacy and 1.5 obstetrics) for NDs approved by OBNM

  • Introduction to Transgender Health Care and HRT

    Original Date: June 7, 2014
    Presenter: Suzanne Scopes, ND

    Transgender patients seek hormone prescribers and primary care services from conventional medical as well as naturopathic physicians. This underserved group of patients have unique needs and face discrimination in most health care settings. All primary care providers should have familiarity with the basics of transgender health care. Covered topics will include hormone prescribing and management; including safety and monitoring of trans patients on hormone protocols.

    1.5 CEUs (0.75 general and 0.75 pharmacy) for NDs approved by OBNM

  • Pharmacodynamics of Bio Identical Hormone Replacement Therapy

    Original Date: June 7, 2014
    Presenter: Natalie Gustafson, Pharm D

    Understanding the various types of dosage forms used in hormone replacement therapy can greatly impact your clinical practice by allowing you to customize the optimal therapies for your patients. There are many factors to consider for each type, including pharmacodynamics, testing, ease of use, and ingredients that are not necessarily obvious. In this talk, the benefits and negatives of each form will be discussed to better specialize your practice.

    1.5 pharmacy CEUs for NDs approved by OBNM

  • Herpes Simplex Virus: An Overview

    Original Date: June 8, 2014
    Presenter: Lisa Taulbee, ND

    Genital herpes is the main cause of genital ulcer disease worldwide. In the United States, about one out of every six people aged 14 to 49 years have genital herpes, yet many clinicians do not evaluate for this in routine sexually transmitted infection screening. Some practitioners are unaware that screening tests for HSV are available. This talk will review the most current and accurate testing options, treatment recommendations and general information regarding HSV in order for clinicians to provide useful counseling sessions to their patients.

    1.5 CEUs (1.25 general and 0.25 pharmacy) for NDs approved by OBNM

  • Supporting Parents in Vaccine Choices

    Original Date: June 8, 2014
    Presenter: Hilary Andrews, ND

    The Center for Disease Control (CDC) recommends, and State health departments mandate, that children be vaccinated for fourteen different diseases before fifteen months of age, most of which are administered in multiple doses which results in as many as twenty six doses of single and combined vaccines administered in the first fifteen months of age. This number is ever increasing as new vaccines are added to the childhood immunization schedule.

    This ninety minute lecture will walk physicians through a vaccine consultation with parents and will present ways to support and educate parents with their vaccines decisions. The lecture will review the current safety concerns regarding vaccines and the CDC childhood immunization schedule, and lastly will detail ways to create individualized/customized approaches to the immunizing children as well as alternatives to immunizing.


    1.5 pharmacy CEUs for NDs approved by OBNM

  • A Current Review in the Diagnosis and Treatment of Osteoporosis

    Original Date: June 8, 2014
    Presenter: Wendy Ellis, ND

    This comprehensive review of osteoporosis will cover risk factors in the development of osteoporosis, including concomitant conditions that may contribute to bone loss, as well as a thorough approach to treatment. Osteoporosis must address gastrointestinal function, hormonal support, nutritional support and lifestyle counseling. Osteoporosis can be reversed in many cases with the adequate tools.
    This lecture will cover the foundational approach to treatment and include case reviews outlining the impacts of hormonal changes, (estrogens, androgens, cortisol and thyroid), lifestyle considerations, gastrointestinal impacts, medications (PPI, prednisone, etc...), and chronic disease in the development of osteoporosis.

    1.5 CEUs (1.25 general and 0.25 pharmacy) for NDs approved by OBNM

  • Rehabbing Pelvic Floor Dysfunction

    Original Date: June 8, 2014
    Presenter: Jill Ghormley, ND

    This lecture is designed to help practitioners understand more about pelvic floor
    dysfunctions and utilize simple assessment and treatment techniques to begin applying healing in pelvic floor problems. The discussion will center around understanding how pelvic floor dysfunction is directly related to many of the pathologies we treat today and the importance of including additional support with respect to pelvic anomaly. Clinical cases involving the parasympathetic nervous system and cranium will also be address in relation to pelvic movement.

    1.5 general CEUs for NDs approved by OBNM

  • Impact of Environmental Xenoestrogens on Breast Tissue

    Original Date: June 8, 2014
    Presenter: Ingrid Edstrom, NP

    This presentation offers an overview of thermography and how it is used to evaluate metabolic and physiological activity in breast tissue as an adjunctive risk assessment tool. It will discuss the significance of environmental impacts outweighing genetics in regards to breast cancer risk. In addition, it will specify metabolic effects of pesticides, herbicides, bovine growth hormones and a non-organic diet on breast tissue. It will explain how these findings may be altered by eating organically, optimizing thyroid function, lifestyle / dietary changes, and appropriate hormone balancing.

    1.5 general CEUs for NDs approved by OBNM